Navidea Biopharmaceuticals Inc. (NAVB) tumbled -23.26% or -0.4 to $1.32. It is near 54839 shares traded, which is 92.97% compare to the average total volume 58985. The market cap of NAVB is $13.27 million. The year to date change is -48.25%. The 52 week price range is from $1.21 to $7.39. Price of NAVB have changed 23.74% during last week. It have changed -28.63% over last month, -48.50% over last 3 months, -57.00% over last 6 months and -59.09% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NAVB is 2.45. It is 85.61% above current price. The 200-day Moving Averages for NAVB is 3.34. It is 153.03% above current price. The 52-week High is 7.39. It is 459.85% from the current price. The 52-week Low is 1.21. It is -8.33% from current price.
There are some statistics of NAVB. It is has market cap $13.27 million. The share outstanding is 10.05 million. The average volume is 58985. The percent of top 15 Institution holding is 6.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NAVB is -709.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NAVB is -109.06%.